Table 3 |
|||
|
Histopathological scoring of osmotic nephrosis-like lesions, proliferating nuclear antigen and activated macrophages |
|||
|
HES 200 |
HES 130 |
RL |
|
|
|
|||
|
OL (score) |
2.1 ± 0.6 |
2.0 ± 0.5 |
1.1 ± 0.4a |
|
PCNA (pc/vf) |
18.8 ± 7.1 |
7.2 ± 1.7b |
14.1 ± 4.1 |
|
Interstitial |
18.0 ± 6.9 |
6.5 ± 1.6c |
13.5 ± 4.0 |
|
Glomerular |
1.2 ± 0.7 |
1.0 ± 0.3 |
0.9 ± 0.2 |
|
ED-1 (pc/vf) |
1.3 ± 1.0 |
0.2 ± 0.04d |
0.4 ± 0.3 |
|
|
|||
|
Data are presented as mean ± standard deviation. a RL vs. 10% HES 200/0.5 and RL vs. 6% HES 130/0.42; P = 0.002 b 6% HES 130/0.42 vs. 10% HES 200/0.5; P = 0.008 c 6% HES 130/0.42 vs. 10% HES 200/0.5; P = 0.006 d 6% HES 130/0.42 vs. 10% HES 200/0.5; P = 0.044 ED-1 = activated macrophages; HES = hydroxyethyl starch; OL = osmotic nephrosis-like lesions; PCNA = proliferating nuclear antigen; RL = Ringer's lactate. |
|||
|
Hüter et al. Critical Care 2009 13:R23 doi:10.1186/cc7726 |
|||